Optimal low-dispersion low-dissipation LBM schemes for computational aeroacoustics

Lattice Boltmzmann Methods (LBM) have been proved to be very effective methods for computational aeroacoustics (CAA), which have been used to capture the dynamics of weak acoustic fluctuations. In this paper, we propose a strategy to reduce the dispersive and disspative errors of the two-dimensional (2D) multi-relaxation-time lattice Boltzmann method (MRT-LBM). By presenting an effective algorithm, we obtain a uniform form of the linearized Navier-Stokes equations corresponding to the MRT-LBM in wave-number space. Using the matrix perturbation theory and the equivalent modified equation approach for finite difference methods, we propose a class of minimization problems to optimize the free-parameters in the MRT-LBM. We obtain this way a dispersion-relation-preserving LBM (DRP-LBM) to circumvent the minimized dispersion error of the MRT-LBM. The dissipation relation precision is also improved.And the stability of the MRT-LBM with the small bulk viscosity is guaranteed. Von Neuman analysis of the linearized MRT-LBM is performed to validate the optimized dispersion/dissipation relations considering monochromatic wave solutions. Meanwhile, dispersion and dissipation errors of the optimized MRT-LBM are quantitatively compared with the original MRT-LBM . Finally, some numerical simulations are carried out to assess the new optimized MRT-LBM schemes.Comment: 33 page

On the Complexity of Solving Zero-Dimensional Polynomial Systems via Projection

Given a zero-dimensional polynomial system consisting of n integer polynomials in n variables, we propose a certified and complete method to compute all complex solutions of the system as well as a corresponding separating linear form l with coefficients of small bit size. For computing l, we need to project the solutions into one dimension along O(n) distinct directions but no further algebraic manipulations. The solutions are then directly reconstructed from the considered projections. The first step is deterministic, whereas the second step uses randomization, thus being Las-Vegas. The theoretical analysis of our approach shows that the overall cost for the two problems considered above is dominated by the cost of carrying out the projections. We also give bounds on the bit complexity of our algorithms that are exclusively stated in terms of the number of variables, the total degree and the bitsize of the input polynomials

Virological efficacy of PI monotherapy for HIV-1 in clinical practice.

BACKGROUND: Clinical trials of PI monotherapy indicate that most participants maintain viral suppression and emergent protease resistance is rare. However, outcomes among patients receiving PI monotherapy for clinical reasons, such as toxicity or adherence issues, are less well studied. METHODS: An observational study of patients attending an HIV treatment centre in London, UK, who had received PI monotherapy between 2004 and 2013, was conducted using prospectively collected clinical data and genotypic resistance reports. Survival analysis techniques were used to examine the times to virological failure and treatment discontinuation. RESULTS: Ninety-five patients had PI monotherapy treatment for a median duration of 126 weeks. Virological failure occurred during 64% of episodes and 8% of patients developed emergent protease mutations. We estimate failure occurs in half of episodes within 2 years following initiation. Where PI monotherapy was continued following virological failure, 68% of patients achieved viral re-suppression. Despite a high incidence of virological failure, many patients continued PI monotherapy and 79% of episodes were ongoing at the end of the study. The type of PI used, the presence of baseline protease mutations and the plasma HIV RNA at initiation did not have a significant impact on treatment outcomes. CONCLUSIONS: There was a higher incidence of virological failure and emerging resistance in our UK clinical setting than described in PI monotherapy clinical trials and other European observational studies. Despite this, many patients continued PI monotherapy and regained viral suppression, indicating this strategy remains a viable option in certain individuals following careful clinical evaluation

LE PROLAPSUS RECTAL DE L'ADULTE

The rectal prolapse is the result of the anus, rectum, over its entire circumference. It is a rare disease in our context. It is said Mucosal or incomplete when it concerns the mucosa . It is a total prolapse or complete if it is all tunics. There are two clinical forms: prolapse of the young men that is rare and primitive injury occurring intermittently during the effort on a solid outdated prolapse of older women who often secondary toÊ permanent injuries acquired. The diagnosis is easy but it is important to take stock keeper, causative anatomical and functional. Complications are rare kind of strange or ulceration of the mucosa. Surgery is the only definitive treatment.Le prolapsus rectal est l'issue par l'anus, du rectum, sur toute sa circonférence. C'est une pathologie peu fréquente dans notre contexte. Il est dit muqueux ou incomplet lorsqu'il ne concerne que la muqueuse. C'est un prolapsus total ou complet s'il s'agit de toutes les tuniques. On distingue deux formes cliniques : Le prolapsus du jeune masculin qui est rare ; lésion primitive et intermittente survenant lors de l'effort sur un périmé solide Le prolapsus de la femme âgée qui est fréquent permanent secondaire à des lésions acquises. Le diagnostic est facile mais il importe de faire un bilan soigneur, étiologique anatomique et fonctionnel. Les complications sont rares à type d'étrangement ou d'ulcération de la muqueuse. La chirurgie  est le seul traitement définitif

Sparse Rational Univariate Representation

International audienceWe present explicit worst case degree and height bounds for the rational univariate representation of the isolated roots of polynomial systems based on mixed volume. We base our estimations on height bounds of resultants and we consider the case of 0-dimensional, positive dimensional, and parametric polynomial systems

Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria

BACKGROUND: Deep sequencing could improve understanding of HIV treatment failure and viral population dynamics. However, this tool is often inaccessible in low- and middle-income countries. OBJECTIVES: To determine the genetic patterns of resistance emerging in West African HIV-1 subtypes during first-line virological failure, and the implications for future antiretroviral options. PATIENTS AND METHODS: Participants were selected from a Nigerian cohort of people living with HIV who had failed first-line ART and subsequently switched to second-line therapy. Whole HIV-1 genome sequences were generated from first-line virological failure samples with Illumina MiSeq. Mutations detected at ≥2% frequency were analysed and compared by subtype. RESULTS: HIV-1 sequences were obtained from 101 participants (65% female, median age 30 years, median 32.9 months of nevirapine- or efavirenz-based ART). Thymidine analogue mutations (TAMs) were detected in 61%, other core NRTI mutations in 92% and NNRTI mutations in 99%. Minority variants (<20% frequency) comprised 18% of all mutations. K65R was more prevalent in CRF02_AG than G subtypes (33% versus 7%; P = 0.002), and ≥3 TAMs were more common in G than CRF02_AG (52% versus 24%; P = 0.004). Subtype G viruses also contained more RT cleavage site mutations. Cross-resistance to at least one of the newer NNRTIs, doravirine, etravirine or rilpivirine, was predicted in 81% of participants. CONCLUSIONS: Extensive drug resistance had accumulated in people with West African HIV-1 subtypes, prior to second-line ART. Deep sequencing significantly increased the detection of resistance-associated mutations. Caution should be used if considering newer-generation NNRTI agents in this setting

Use of plasma human herpesvirus-8 viral load measurement: evaluation of practice in three UK HIV treatment centres

A retrospective audit of plasma human herpesvirus-8 (HHV-8) viral load testing was performed in three HIV treatment centres over 24 months. Reasons for testing (360 tests) were: symptoms of systemic inflammatory response syndrome (SIRS) (fever, lymphadenopathy and raised inflammatory markers); monitoring in known HHV-8 pathology other than Kaposi sarcoma (KS); investigation of known/suspected KS, and other/no reason. Of patients with multicentric Castleman disease (MCD), 14/16 (88%) had detectable plasma HHV-8, as did 27/45 (60%) with biopsy proven or clinically confirmed KS, and 6/19 (32%) with lymphoma. Neither of the two patients with MCD and no detectable HHV-8 had SIRS symptoms at the time of the test. There was wide variation between centres in the indications prompting HHV-8 testing, with a more conservative approach resulting in a higher proportion of positive results. Measuring plasma HHV-8 in the absence of SIRS symptoms, established HHV-8 disease monitoring, or confirmed/suspected KS is unlikely to yield detectable HHV-8 thus allowing potential cost savings

Prise en charge du couple mère enfant de la varicelle pendant la grossesse

La varicelle est une maladie généralement bénigne chez l’enfant, cependant l’atteinte de l’adulte est potentiellement grave et son association à la grossesse expose la mère et le nouveau né à des risques de complications plus redoutables.La prise en charge multidisciplinaire associant obstétricien, biologiste et pédiatre est indispensable pour limiter les effets délétères de l’infection par la varicelle pendant la grossesse.Nous rapportons dans cet article les approches thérapeutiques actuellement proposées pour la prise en charge anté et péripartum du couple mère-enfant en cas d’infection par la varicelle pendant la grossesse et nous proposons des conduites visant à atténuer les complications maternelles